HK Stock MarketDetailed Quotes

CHINA ALUMCAN (06898)

Watchlist
  • 0.710
  • 0.0000.00%
Market Closed Jan 16 15:57 CST
670.27MMarket Cap41.76P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHINA ALUMCAN (06898) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
Turnover
-1.71%117.62M
-3.27%227.8M
-3.98%119.66M
11.87%235.51M
10.54%124.62M
0.77%210.51M
5.76%112.73M
13.58%208.9M
8.13%106.59M
-10.70%183.92M
Operating income
-1.71%117.62M
-3.27%227.8M
-3.98%119.66M
11.87%235.51M
10.54%124.62M
0.77%210.51M
5.76%112.73M
13.58%208.9M
8.13%106.59M
-10.70%183.92M
Cost of sales
-3.87%-87.49M
-0.25%-166.33M
3.41%-84.23M
-6.32%-165.91M
-5.03%-87.2M
-2.47%-156.05M
-11.72%-83.02M
-28.17%-152.29M
-20.73%-74.32M
11.50%-118.82M
Operating expenses
-3.87%-87.49M
-0.25%-166.33M
3.41%-84.23M
-6.32%-165.91M
-5.03%-87.2M
-2.47%-156.05M
-11.72%-83.02M
-28.17%-152.29M
-20.73%-74.32M
11.50%-118.82M
Gross profit
-14.96%30.13M
-11.68%61.47M
-5.30%35.43M
27.79%69.6M
25.94%37.41M
-3.80%54.46M
-7.94%29.71M
-13.04%56.62M
-12.82%32.27M
-9.19%65.11M
Selling expenses
19.57%-1.66M
10.70%-4.41M
50.75%-2.07M
29.36%-4.94M
-23.30%-4.2M
15.12%-6.99M
17.84%-3.41M
-12.65%-8.23M
-12.32%-4.15M
24.73%-7.31M
Administrative expenses
14.59%-9.77M
0.22%-25.59M
-0.86%-11.44M
-16.96%-25.65M
-18.15%-11.34M
-2.31%-21.93M
4.07%-9.6M
-3.65%-21.43M
0.27%-10.01M
15.15%-20.68M
Research and development expenses
4.35%-4.59M
-5.86%-10.93M
3.79%-4.8M
6.35%-10.32M
14.06%-4.99M
3.69%-11.02M
-8.52%-5.81M
-9.51%-11.45M
-9.85%-5.35M
21.56%-10.45M
Impairment and provision
-148.47%-237K
309.15%663K
413.46%489K
-65.10%-317K
79.90%-156K
81.73%-192K
-7.78%-776K
-98.68%-1.05M
-5.26%-720K
-21.33%-529K
-Other impairment is provision
-148.47%-237K
309.15%663K
413.46%489K
-65.10%-317K
79.90%-156K
81.73%-192K
-7.78%-776K
-98.68%-1.05M
-5.26%-720K
-21.33%-529K
Special items of operating profit
32.26%4.83M
109.96%2.99M
-36.46%3.66M
-83.80%1.43M
25.23%5.75M
34.50%8.8M
28.19%4.59M
137.73%6.54M
193.21%3.58M
-67.40%2.75M
Operating profit
-12.07%18.7M
-18.79%24.2M
-5.39%21.26M
28.84%29.8M
52.79%22.48M
10.16%23.13M
-5.88%14.71M
-27.33%21M
-17.56%15.63M
-10.54%28.89M
Financing cost
33.33%-6K
-25.00%-20K
-12.50%-9K
42.86%-16K
55.56%-8K
71.72%-28K
78.05%-18K
37.34%-99K
-24.24%-82K
-31.67%-158K
Earning before tax
-12.06%18.69M
-18.82%24.18M
-5.39%21.26M
28.93%29.79M
52.92%22.47M
10.55%23.1M
-5.50%14.69M
-27.28%20.9M
-17.70%15.55M
-10.70%28.74M
Tax
6.25%-4.48M
30.80%-5.47M
3.57%-4.78M
-253.18%-7.9M
-268.70%-4.96M
9.80%-2.24M
48.98%-1.35M
62.79%-2.48M
43.29%-2.64M
11.91%-6.66M
After-tax profit from continuing operations
-13.74%14.21M
-14.50%18.72M
-5.91%16.47M
4.90%21.89M
31.18%17.51M
13.29%20.87M
3.38%13.35M
-16.55%18.42M
-9.35%12.91M
-10.32%22.07M
Earning after tax
-13.74%14.21M
-14.50%18.72M
-5.91%16.47M
4.90%21.89M
31.18%17.51M
13.29%20.87M
3.38%13.35M
-16.55%18.42M
-9.35%12.91M
-45.07%22.07M
Minority profit
-10.92%253K
-18.41%350K
-4.70%284K
21.19%429K
33.04%298K
9.60%354K
12.56%224K
-20.05%323K
-21.96%199K
-59.64%404K
Profit attributable to shareholders
-13.79%13.96M
-14.42%18.37M
-5.93%16.19M
4.62%21.46M
31.14%17.21M
13.36%20.51M
3.23%13.12M
-16.49%18.1M
-9.12%12.71M
-44.70%21.67M
Basic earnings per share
-11.76%0.015
-20.83%0.019
-10.53%0.017
4.35%0.024
26.67%0.019
15.00%0.023
7.14%0.015
-16.67%0.02
-12.50%0.014
-42.86%0.024
Diluted earnings per share
-7.69%0.012
-6.25%0.015
0.00%0.013
6.67%0.016
30.00%0.013
15.38%0.015
11.11%0.01
-18.75%0.013
-10.00%0.009
-51.52%0.016
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young Accounting Firm
--
Ernst & Young
--
Ernst & Young Accounting Firm
--
Ernst & Young Accounting Firm
(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020
Turnover -1.71%117.62M-3.27%227.8M-3.98%119.66M11.87%235.51M10.54%124.62M0.77%210.51M5.76%112.73M13.58%208.9M8.13%106.59M-10.70%183.92M
Operating income -1.71%117.62M-3.27%227.8M-3.98%119.66M11.87%235.51M10.54%124.62M0.77%210.51M5.76%112.73M13.58%208.9M8.13%106.59M-10.70%183.92M
Cost of sales -3.87%-87.49M-0.25%-166.33M3.41%-84.23M-6.32%-165.91M-5.03%-87.2M-2.47%-156.05M-11.72%-83.02M-28.17%-152.29M-20.73%-74.32M11.50%-118.82M
Operating expenses -3.87%-87.49M-0.25%-166.33M3.41%-84.23M-6.32%-165.91M-5.03%-87.2M-2.47%-156.05M-11.72%-83.02M-28.17%-152.29M-20.73%-74.32M11.50%-118.82M
Gross profit -14.96%30.13M-11.68%61.47M-5.30%35.43M27.79%69.6M25.94%37.41M-3.80%54.46M-7.94%29.71M-13.04%56.62M-12.82%32.27M-9.19%65.11M
Selling expenses 19.57%-1.66M10.70%-4.41M50.75%-2.07M29.36%-4.94M-23.30%-4.2M15.12%-6.99M17.84%-3.41M-12.65%-8.23M-12.32%-4.15M24.73%-7.31M
Administrative expenses 14.59%-9.77M0.22%-25.59M-0.86%-11.44M-16.96%-25.65M-18.15%-11.34M-2.31%-21.93M4.07%-9.6M-3.65%-21.43M0.27%-10.01M15.15%-20.68M
Research and development expenses 4.35%-4.59M-5.86%-10.93M3.79%-4.8M6.35%-10.32M14.06%-4.99M3.69%-11.02M-8.52%-5.81M-9.51%-11.45M-9.85%-5.35M21.56%-10.45M
Impairment and provision -148.47%-237K309.15%663K413.46%489K-65.10%-317K79.90%-156K81.73%-192K-7.78%-776K-98.68%-1.05M-5.26%-720K-21.33%-529K
-Other impairment is provision -148.47%-237K309.15%663K413.46%489K-65.10%-317K79.90%-156K81.73%-192K-7.78%-776K-98.68%-1.05M-5.26%-720K-21.33%-529K
Special items of operating profit 32.26%4.83M109.96%2.99M-36.46%3.66M-83.80%1.43M25.23%5.75M34.50%8.8M28.19%4.59M137.73%6.54M193.21%3.58M-67.40%2.75M
Operating profit -12.07%18.7M-18.79%24.2M-5.39%21.26M28.84%29.8M52.79%22.48M10.16%23.13M-5.88%14.71M-27.33%21M-17.56%15.63M-10.54%28.89M
Financing cost 33.33%-6K-25.00%-20K-12.50%-9K42.86%-16K55.56%-8K71.72%-28K78.05%-18K37.34%-99K-24.24%-82K-31.67%-158K
Earning before tax -12.06%18.69M-18.82%24.18M-5.39%21.26M28.93%29.79M52.92%22.47M10.55%23.1M-5.50%14.69M-27.28%20.9M-17.70%15.55M-10.70%28.74M
Tax 6.25%-4.48M30.80%-5.47M3.57%-4.78M-253.18%-7.9M-268.70%-4.96M9.80%-2.24M48.98%-1.35M62.79%-2.48M43.29%-2.64M11.91%-6.66M
After-tax profit from continuing operations -13.74%14.21M-14.50%18.72M-5.91%16.47M4.90%21.89M31.18%17.51M13.29%20.87M3.38%13.35M-16.55%18.42M-9.35%12.91M-10.32%22.07M
Earning after tax -13.74%14.21M-14.50%18.72M-5.91%16.47M4.90%21.89M31.18%17.51M13.29%20.87M3.38%13.35M-16.55%18.42M-9.35%12.91M-45.07%22.07M
Minority profit -10.92%253K-18.41%350K-4.70%284K21.19%429K33.04%298K9.60%354K12.56%224K-20.05%323K-21.96%199K-59.64%404K
Profit attributable to shareholders -13.79%13.96M-14.42%18.37M-5.93%16.19M4.62%21.46M31.14%17.21M13.36%20.51M3.23%13.12M-16.49%18.1M-9.12%12.71M-44.70%21.67M
Basic earnings per share -11.76%0.015-20.83%0.019-10.53%0.0174.35%0.02426.67%0.01915.00%0.0237.14%0.015-16.67%0.02-12.50%0.014-42.86%0.024
Diluted earnings per share -7.69%0.012-6.25%0.0150.00%0.0136.67%0.01630.00%0.01315.38%0.01511.11%0.01-18.75%0.013-10.00%0.009-51.52%0.016
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young Accounting Firm--Ernst & Young--Ernst & Young Accounting Firm--Ernst & Young Accounting Firm

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
New Consumption Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.88%
Sample Name
Sample Code
 +6.48%
Sample Name
Sample Code
 +4.52%
4
GIANT BIOGENE
02367
+4.07%
5
BLOKS
00325
+2.72%
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More
Are you foolish? What's the point of knowing your mistakes?
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?

- No more -